Roxane du Berger

3.1k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Roxane du Berger is a scholar working on Statistics and Probability, Rheumatology and Geriatrics and Gerontology. According to data from OpenAlex, Roxane du Berger has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Statistics and Probability, 4 papers in Rheumatology and 3 papers in Geriatrics and Gerontology. Recurrent topics in Roxane du Berger's work include Statistical Methods and Bayesian Inference (4 papers), Advanced Statistical Methods and Models (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Roxane du Berger is often cited by papers focused on Statistical Methods and Bayesian Inference (4 papers), Advanced Statistical Methods and Models (3 papers) and Systemic Lupus Erythematosus Research (3 papers). Roxane du Berger collaborates with scholars based in Canada, United States and United Kingdom. Roxane du Berger's co-authors include Michał Abrahamowicz, Paul R. Fortin, Ann E. Clarke, Yin Li, Steven A. Grover, Tamara Grodzicky, Lawrence Joseph, Robyn Tamblyn, David B. Wolfson and Patrick Bélisle and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Epidemiology.

In The Last Decade

Roxane du Berger

21 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

2001 908 citations Michał Abrahamowicz, Tamara Grodzicky et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roxane du Berger Canada	19	1.0k	745	296	269	252	21	2.3k
Glen Hazlewood Canada	26	1.3k 1.2×	456 0.6×	117 0.4×	413 1.5×	169 0.7×	157	3.9k
Sylvain Mathieu France	26	1.1k 1.1×	300 0.4×	75 0.3×	272 1.0×	146 0.6×	92	2.4k
Bruce Crawford United States	25	734 0.7×	209 0.3×	77 0.3×	168 0.6×	127 0.5×	79	2.8k
Andrew P. Yu United States	33	433 0.4×	719 1.0×	86 0.3×	201 0.7×	96 0.4×	80	3.7k
Peter K. K. Wong Australia	21	431 0.4×	298 0.4×	65 0.2×	177 0.7×	273 1.1×	64	3.3k
Hubert J. A. Schouten Netherlands	28	778 0.8×	101 0.1×	269 0.9×	161 0.6×	327 1.3×	62	2.9k
Roberta Ara United Kingdom	27	348 0.3×	184 0.2×	64 0.2×	196 0.7×	245 1.0×	63	2.7k
Yuan‐I Min United States	20	324 0.3×	117 0.2×	72 0.2×	271 1.0×	317 1.3×	48	2.1k
Ralph Brinks Germany	24	673 0.7×	358 0.5×	24 0.1×	239 0.9×	93 0.4×	133	1.9k
Thomas Mittendorf Germany	23	441 0.4×	253 0.3×	29 0.1×	146 0.5×	68 0.3×	105	1.7k

Countries citing papers authored by Roxane du Berger

Since Specialization

Citations

This map shows the geographic impact of Roxane du Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxane du Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxane du Berger more than expected).

Fields of papers citing papers by Roxane du Berger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roxane du Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxane du Berger. The network helps show where Roxane du Berger may publish in the future.

Co-authorship network of co-authors of Roxane du Berger

This figure shows the co-authorship network connecting the top 25 collaborators of Roxane du Berger. A scholar is included among the top collaborators of Roxane du Berger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roxane du Berger. Roxane du Berger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamblyn, Robyn, Michał Abrahamowicz, Dale Dauphinée, et al.. (2007). Physician Scores on a National Clinical Skills Examination as Predictors of Complaints to Medical Regulatory Authorities. JAMA. 298(9). 993–993. 321 indexed citations

Abrahamowicz, Michał, Gillian Bartlett, Robyn Tamblyn, & Roxane du Berger. (2006). Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries. Journal of Clinical Epidemiology. 59(4). 393–403. 65 indexed citations

Vidal, Vincent, Éric Thérasse, Yves Berthiaume, et al.. (2006). Bronchial Artery Embolization in Adults with Cystic Fibrosis: Impact on the Clinical Course and Survival. Journal of Vascular and Interventional Radiology. 17(6). 953–958. 40 indexed citations

Tamblyn, Robyn, Michał Abrahamowicz, Roxane du Berger, Peter J. McLeod, & Gillian Bartlett. (2005). A 5‐Year Prospective Assessment of the Risk Associated with Individual Benzodiazepines and Doses in New Elderly Users. Journal of the American Geriatrics Society. 53(2). 233–241. 91 indexed citations

Richardson, Harriet, Michał Abrahamowicz, Pierre‐Paul Tellier, et al.. (2005). Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students. Cancer Epidemiology Biomarkers & Prevention. 14(5). 1149–1156. 66 indexed citations

Bartlett, Gillian, Michał Abrahamowicz, Robyn Tamblyn, et al.. (2003). Longitudinal patterns of new Benzodiazepine use in the elderly. Pharmacoepidemiology and Drug Safety. 13(10). 669–682. 44 indexed citations

Berger, Roxane du, Daniel Krewski, Richard T. Burnett, et al.. (2003). Bias due to aggregation of individual covariates in the cox regression model. Annals of Epidemiology. 13(8). 583–583. 2 indexed citations

Abrahamowicz, Michał, et al.. (2003). Flexible Modeling of Exposure-Response Relationship between Long-Term Average Levels of Particulate Air Pollution and Mortality in the American Cancer Society Study. Journal of Toxicology and Environmental Health. 66(16-19). 1625–1654. 43 indexed citations

Abrahamowicz, Michał, Tamara Grodzicky, Yin Li, et al.. (2001). Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis & Rheumatism. 44(10). 2331–2337. 908 indexed citations breakdown →

10.

Neville, Carolyn, Paul R. Fortin, Mary‐Ann Fitzcharles, et al.. (1999). The needs of patients with arthritis: The patient's perspective. Arthritis & Rheumatism. 12(2). 85–95. 60 indexed citations

11.

Bélisle, Patrick, et al.. (1998). Change-Point Analysis of Neuron Spike Train Data. Biometrics. 54(1). 113–113. 25 indexed citations

12.

Abrahamowicz, Michał, Paul R. Fortin, Roxane du Berger, et al.. (1998). The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.. PubMed. 25(2). 277–84. 83 indexed citations

13.

Bélisle, Patrick, Lawrence Joseph, Brenda MacGibbon, David B. Wolfson, & Roxane du Berger. (1998). Change-point analysis of neuron spike train data.. PubMed. 54(1). 113–23. 22 indexed citations

14.

Fortin, Paul R., Michał Abrahamowicz, Carolyn Neville, et al.. (1998). Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 7(2). 101–107. 107 indexed citations

15.

Abrahamowicz, Michał, et al.. (1997). Flexible Modeling of the Effects of Serum Cholesterol on Coronary Heart Disease Mortality. American Journal of Epidemiology. 145(8). 714–729. 44 indexed citations

16.

Joseph, Lawrence, Roxane du Berger, & Patrick Bélisle. (1997). BAYESIAN AND MIXED BAYESIAN/LIKELIHOOD CRITERIA FOR SAMPLE SIZE DETERMINATION. Statistics in Medicine. 16(7). 769–781. 113 indexed citations

17.

Joseph, Lawrence, David B. Wolfson, & Roxane du Berger. (1995). Sample Size Calculations for Binomial Proportions via Highest Posterior Density Intervals. Journal of the Royal Statistical Society Series D (The Statistician). 44(2). 143–143. 106 indexed citations

18.

Joseph, Lawrence, David B. Wolfson, & Roxane du Berger. (1995). Some Comments on Bayesian Sample Size Determination. Journal of the Royal Statistical Society Series D (The Statistician). 44(2). 167–167. 26 indexed citations

19.

Ciampi, Antonio, et al.. (1991). RECPAM: A computer program for recursive partition and amalgamation for survival data and other situations frequently occurring in biostatistics. III. Classification according to a multivariate construct. Application to data on Haemophilus influenzae type b meningitis. Computer Methods and Programs in Biomedicine. 36(1). 51–61. 5 indexed citations

20.

Taylor, H. Gerry, Elaine L. Mills, Antonio Ciampi, et al.. (1990). The Sequelae ofHaemophilus influenzaeMeningitis in School-Age Children. New England Journal of Medicine. 323(24). 1657–1663. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact